<scp>HPV</scp> vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression
HPV vaccination did not reduce the risk of progression in women undergoing active surveillance for CIN2. This finding indicates that HPV vaccination should not be recommended in this group of women.
Authors
- Megan A. Clarke (ORCID: https://orcid.org/0000-0003-0435-7376)
- Kathrine Dyhr Lycke (ORCID: https://orcid.org/0000-0003-1657-8600)
- Eva Bjerre Ostenfeld (ORCID: https://orcid.org/0000-0003-4125-4317)
- Anne Sofie Hammer (ORCID: https://orcid.org/0000-0001-9690-2225)
- Louise Krog (ORCID: https://orcid.org/0000-0001-7237-4536)
- Dina Overgaard Eriksen (ORCID: https://orcid.org/0000-0002-7155-6140)
- Therese Koops Grønborg (ORCID: https://orcid.org/0000-0001-6583-3319)
- Nicolas Wentzensen
- Pernille T. Jensen
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Regionshospitalet Herning (DK)
- National Cancer Institute (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- Acta Obstetricia Et Gynecologica Scandinavica
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1111/aogs.70128
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00